JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• 无栏目 • Previous Articles     Next Articles

Expressions of EGFR, NM23 and BCL2 in hypopharyngeal cancer and their clinical significance　

YANG Qiuan1,　YANG Jinxia1,　FU Weijiang1,　ZHANG Tingguo2,　WANG Yan2,　LIU Wenjun2,　ZHANG Xiaomei1,　ZHAO Weiping1
   

  1. (1. Cancer Center; 2 Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, China)
  • Received:1900-01-01 Revised:1900-01-01 Published:2009-04-16
  • Contact: ZHAO Weiping

PDF (PC)

205

Abstract: To investigate expressions of EGFR, NM23 and Bcl2 in hypopharyngeal cancer and their correlation with clinicopathological risks. MethodsExpressions EGFR, NM23 and Bcl2 in 29 cases of hypopharyngeal cancer were determined with an immunohistochemical SP method. ResultsExpressions of EGFR, NM23 and Bcl2 in hypopharyngeal cancer were 62% (18/29), 79% (23/29) and 86% (25/29) respectively. The EGFR level in poorly differentiated cancer was significantly higher than that in well or moderately differentiated cancer (P=0.021), and the EGFR level in the group with unilateral and bilateral lymph node metastases was significantly higher than that in the group without lymph node metastases (P=0.018). However, expressions of NM23 and Bcl2 had no correlation with clinicopathological changes. ConclusionExpression of EFGR is correlated with pathological differentiation and lymph node metastasis, and EFGR may be a potential biomarker for assessing hypopharyngeal cancer. NM23 and Bcl2 need to be further warranted.

Key words: Hypopharyngeal cancer, Epidermal growth factor receptor, NM23, B cell lymphoma

CLC Number: 

  • R739.63
[1] CHENG Yueqi, WANG Fei, YU Lixiang, ZHENG Chao, YU Zhigang. Progress in the study of trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 17-24.
[2] YANG Xuemei, LI Juan, WANG Yifan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Significance of a three-lncRNAs signature on the prediction of survival for HER2 positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 69-76.
[3] WANG Jianli, WANG Xiaojing, SUN Yulian, HU Xiaole, LUAN Xiaorong. Clinical effect of gefitinib combined with chemotherapy on patients with advanced non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(11): 20-26.
[4] XU Shuyuan, JI Quanjiang, GUO Li. Effects of serum levels of sEGFR, CEA and Cyfra21-1 on the prognosis of non-small cell lung cancer patients [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 107-111.
[5] SHI Shuyuan, GUAN Zhiyu, SUN Daqiang. Recombinant human vascular endostatin enhances antitumour activity of EGFR-TKIs for lung cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(9): 6-10.
[6] XIE Hounai, LI Meng, XU Lin, WANG Hui, PENG Yue, PENG Zhongmin. Clinical analysis of gefitinib versus pemetrexed combined with cisplatin in patients with stage Ⅱ-ⅢA lung adenocarcinoma harbouring positive EGFR mutations [J]. Journal of Shandong University (Health Sciences), 2018, 56(9): 29-34.
[7] WANG Jing-nan1， ZHENG Yan2， XIAO Dong-jie2， LI Jin-xing1， DING Bu-tong2， LIU Xiang-dong3， WANG Yun-shan2,4. Correlation between  SATB1 and HER2 expressions and
 the tumor grade in breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 91-.
[8] CHENG Zhao-ling, LI Xue-mei, YANG Ting-ting, ZHU Qiang. Expression of TLR 4 in colorectal cancer and its
relationships with FasL and EGFR [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 92-.
[9] LI Qiang， YANG Zhe， ZHAO Ying， HAN Jun-qing. A preliminary study toward validating EGFR expression in esophageal
carcinoma as used to predict the sensitivity to chemoradiotherapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 96-.
[10] MA Yu-hua1,2, ZHENG Yan3, JIA Yan-fei3, WANG Yun-shan3. GFR and DEC1 protein co-expression promotes lymph node
metastasis in lung adenocarcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 24-28.
[11] WANG Ning-ning, SHEN Fang-zhen, LIN Ming-gang, YU Li, YAO Ru-yong. Influence of stable transfection of bcl-2shRNA  combined with γ irradiation on apoptosis of the gastric carcinoma cell line SGC-7901 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 31-.
[12] WANG Yong，ZHANG Jiao，REN Wan-hua, LI Tao. Expressions of MTA1, nm23 and c-myc in hepatocellular  carcinoma and their correlations [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 99-.
[13] CHEN Weiguo1, LONG Huimin2, HOU Jianquan1, PU Jinxian1, YAN Chun yin1. Inhibitory effect of Gefitinib on hormone independent prostate cancer in vitro and in vivo [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 52-55.
[14] . Effects of Gefitinib in combination with Celecoxib on apoptosis and expressions of EGFR and COX2 in cancerous lung cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(8): 37-41.
[15] MOU Zhuang-bo,ZHAO You-an,WANG Yan-jun. SiRNA mediated silencing of the epidermal growth factor receptor induces the apoptosis of HepG2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(3): 313-316.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd